<p><h1>IV and Oral Iron Drugs Market Size, Share & Trends Analysis Report By Material, By Type, By End-user, By Region, And Segment Forecasts, 2023 - 2030</h1></p><p><strong>Market Overview and Report Coverage</strong></p>
<p><p>IV (intravenous) and oral iron drugs are medications used to treat iron deficiency anemia, a condition characterized by a low level of red blood cells due to insufficient iron in the body. IV iron drugs are administered through a vein, while oral iron drugs are taken orally.</p><p>The current outlook of the IV and oral iron drugs market is positive and the market is expected to grow at a CAGR of 9.6% during the forecasted period. The increasing prevalence of iron deficiency anemia, which can be attributed to factors such as poor nutrition, chronic diseases, and pregnancy, is driving the demand for these drugs. Additionally, the rising geriatric population and growing awareness about iron deficiency anemia are also contributing to market growth.</p><p>IV iron drugs are preferred in cases of severe iron deficiency anemia or when oral iron drugs are not well-tolerated or ineffective. These drugs have a faster onset of action and are more effective in rapidly replenishing iron stores in the body. However, they require healthcare professionals for administration, which can be a challenge in certain healthcare settings.</p><p>On the other hand, oral iron drugs are more convenient for patients as they can be self-administered at home. They are widely prescribed for mild to moderate cases of iron deficiency anemia. The availability of different formulations and improved tolerability have also increased the adoption of oral iron drugs.</p><p>In the future, the IV and oral iron drugs market is expected to witness advancements and innovations in drug formulations and delivery methods. This may include the development of novel oral iron drugs with enhanced bioavailability and reduced side effects. Additionally, collaborations and partnerships between pharmaceutical companies and healthcare institutions may further drive market growth.</p><p>In conclusion, the IV and oral iron drugs market is expected to experience steady growth in the coming years. Factors such as the increasing prevalence of iron deficiency anemia, rising geriatric population, and advancements in drug formulations are likely to contribute to market expansion. However, challenges related to drug administration and tolerability may impact the market to a certain extent.</p></p>
<p><strong>Get a Sample PDF of the Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1566286">https://www.reliableresearchreports.com/enquiry/request-sample/1566286</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The IV and Oral Iron Drugs Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Oral Iron Drug</li><li>IVIron Drugs</li></ul></p>
<p>&nbsp;</p>
<p><p>The oral iron drug market refers to the segment of the pharmaceutical industry that focuses on medications in tablet or liquid form for the treatment of iron deficiency. These drugs are designed to be taken orally by patients to increase their iron levels. On the other hand, the IV iron drugs market comprises medications that are administered intravenously to address severe or chronic iron deficiencies. These intravenous treatments may be necessary when oral iron drugs are ineffective or not suitable for the patient. Both markets aim to fulfill the iron supplementation needs of individuals with different iron deficiencies.</p></p>
<p><strong>Get a Sample PDF of the Report:</strong>&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1566286">https://www.reliableresearchreports.com/enquiry/request-sample/1566286</a></p>
<p>&nbsp;</p>
<p><strong>The IV and Oral Iron Drugs Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Nephrology</li><li>OBGYN</li><li>Surgeries</li><li>Gastroenterology</li><li>Oncology</li><li>Heart failure (HF)</li></ul></p>
<p>&nbsp;</p>
<p><p>IV and Oral Iron Drugs have various applications in different medical fields. In nephrology, these drugs are used to manage iron deficiency associated with chronic kidney disease. In OBGYN, they are utilized for treating iron deficiency anemia during pregnancy or menstrual disorders. Surgeries often require these drugs to replenish iron levels before or after procedures. Gastroenterology aims to cure iron deficiency caused by conditions like inflammatory bowel disease. In oncology, IV and oral iron drugs help combat anemia associated with cancer treatments. Additionally, in the heart failure (HF) market, these drugs are employed to address iron deficiency in HF patients.</p></p>
<p><strong>Purchase this Report:</strong>&nbsp; <a href="https://www.reliableresearchreports.com/purchase/1566286">https://www.reliableresearchreports.com/purchase/1566286</a></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the IV and Oral Iron Drugs Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p>&nbsp;</p>
<p><strong>What are the Emerging Trends in the Global IV and Oral Iron Drugs market?</strong></p>
<p><p>The global IV and oral iron drugs market is experiencing several emerging trends. Firstly, there is a growing focus on patient-centric care and convenience, leading to the development of more patient-friendly iron formulations and alternative routes of administration. Secondly, with the increasing prevalence of iron deficiency anemia, there is a surge in the demand for iron supplements across various age groups, including children, pregnant women, and the elderly. Additionally, the rising adoption of IV iron therapy in treating conditions like chronic kidney disease and inflammatory bowel disease is driving market growth. Furthermore, technological advancements in drug delivery systems and improved diagnostics are contributing to the market's expansion.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report</strong>- <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1566286">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1566286</a></p>
<p>&nbsp;</p>
<p><strong>Major Market Players</strong></p>
<p><p>Competitive IV and Oral Iron Drugs Market Players:</p><p>1. Daiichi Sankyo Company: Daiichi Sankyo is a global pharmaceutical company headquartered in Japan. It focuses on researching and developing innovative medicines to address various therapeutic areas, including cardiovascular and metabolic diseases, oncology, and disorders of the immune system. Daiichi Sankyo has a strong presence in the IV and oral iron drugs market, offering products like Ferrinject and Maltofer. The company has experienced steady growth in recent years, with its global revenues reaching approximately $9.84 billion in the fiscal year 2020.</p><p>2. Vifor Pharma: Vifor Pharma, based in Switzerland, is a global specialty pharmaceutical company focused on the development and commercialization of innovative medicines for patients with kidney disease and iron deficiency. The company's portfolio includes both IV and oral iron drugs. Vifor Pharma's flagship product, Ferinject, has experienced significant market growth worldwide and is regarded as a leading intravenous iron therapy. In 2020, Vifor Pharma generated total revenues of about $1.64 billion.</p><p>3. Akebia Therapeutics: Akebia Therapeutics, headquartered in the United States, specializes in the development and commercialization of novel treatments for kidney diseases. The company's key product is Auryxia, an oral iron therapy used to treat iron deficiency anemia in patients with chronic kidney disease. Akebia Therapeutics has focused on expanding its market presence by developing strategic partnerships, such as collaborations with Otsuka Pharmaceutical and Mitsubishi Tanabe Pharma. In 2020, the company reported total revenues of approximately $276 million.</p><p>4. AMAG Pharmaceuticals: AMAG Pharmaceuticals is a US-based specialty pharmaceutical company primarily focused on maternal health, anemia management, and hematology/oncology. Its flagship product, Feraheme, is an IV iron replacement therapy indicated for patients with iron deficiency anemia. AMAG Pharmaceuticals has witnessed steady growth in the IV and oral iron drugs market, with total revenues of around $334 million in 2020. The company has recently announced its acquisition by Covis Group, which may further enhance its market position.</p><p>5. Sanofi: Sanofi, a multinational pharmaceutical company headquartered in France, is engaged in the research, development, and distribution of a wide range of healthcare products. The company offers iron supplements like CosmoFer and Venofer in the IV and oral form. Sanofi has a significant global presence and a diversified portfolio of iron products, contributing to its strong market position. In 2020, Sanofi generated total sales of approximately $47.5 billion.</p><p>These selected companies represent a range of well-established players in the competitive IV and oral iron drugs market. Their market growth and revenue figures demonstrate their success in addressing the needs of patients suffering from iron deficiency and related conditions.</p></p>
<p><strong>Purchase this Report:</strong>&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1566286">https://www.reliableresearchreports.com/purchase/1566286</a></p>
<p></p>
<p><strong>Get a Sample PDF of the Report:</strong>&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1566286">https://www.reliableresearchreports.com/enquiry/request-sample/1566286</a></p>
<p><p><a href="https://medium.com/@ginawindler1965/cylindrical-photoelectric-sensors-market-size-growth-forecast-2023-2030-ac001d704625">Cylindrical Photoelectric Sensors Market</a></p><p><a href="https://www.linkedin.com/pulse/solid-alkali-silicates-market-challenges-opportunities-g19ze/">Solid Alkali Silicates Market</a></p><p><a href="https://www.linkedin.com/pulse/digital-integrated-passive-device-market-insights-orxme/">Digital Integrated Passive Device Market</a></p><p><a href="https://www.linkedin.com/pulse/electrostrictive-stack-actuator-market-research-report-uy3fe/">Electrostrictive Stack Actuator Market</a></p><p><a href="https://medium.com/@emmyrolfson8689/array-sensors-market-size-growth-forecast-2023-2030-29f1b7ae151d">Array Sensors Market</a></p></p>